A citation-based method for searching scientific literature

Joan L Walker, C Bethan Powell, Lee-May Chen, Jeanne Carter, Victoria L Bae Jump, Lynn P Parker, Mark E Borowsky, Randall K Gibb. Cancer 2015
Times Cited: 139



Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles, Gabriella Pichert, Laura Van t'veer, Nadine Tung, Jeffrey N Weitzel, Fergus J Couch, Wendy S Rubinstein, Patricia A Ganz, Mary B Daly, Olufunmilayo I Olopade, Gail Tomlinson, Joellen Schildkraut, Joanne L Blum, Timothy R Rebbeck. JAMA 2010
Times Cited: 836




List of shared articles



Times cited

Controversies in Hereditary Cancer Management.
Mariam M AlHilli, Holly J Pederson. Obstet Gynecol 2021
0

Plasma Protein Biomarkers Associated with Higher Ovarian Cancer Risk in BRCA1/2 Carriers.
Hee-Sung Ahn, Jung Yoon Ho, Jiyoung Yu, Jeonghun Yeom, Sanha Lee, Soo Young Hur, Yuyeon Jung, Kyunggon Kim, Youn Jin Choi. Cancers (Basel) 2021
0

Risk-reducing salpingo-oophorectomy and breast cancer incidence among Jewish BRCA1/BRCA2-mutation carriers-an Israeli matched-pair study.
Tamar Perri, Gabriel Levin, Shani Naor-Revel, Perry Eliassi-Revivo, Dror Lifshitz, Eitan Friedman, Jacob Korach. Int J Gynaecol Obstet 2021
0

Targeting progesterone signaling prevents metastatic ovarian cancer.
Olga Kim, Eun Young Park, Sun Young Kwon, Sojin Shin, Robert E Emerson, Yong-Hyun Shin, Francesco J DeMayo, John P Lydon, Donna M Coffey, Shannon M Hawkins,[...]. Proc Natl Acad Sci U S A 2020
5


Contemporary management of adnexa at the time of benign hysterectomy: a review of the literature.
Nupur Tamhane, Anthony N Imudia, Emad Mikhail. J Obstet Gynaecol 2019
1



Cancer Genetic Counseling and Testing: Perspectives of Epithelial Ovarian Cancer Patients and Gynecologic Oncology Healthcare Providers.
Margaret I Liang, Deanna H Wong, Christine S Walsh, Robin Farias-Eisner, Joshua G Cohen. J Genet Couns 2018
10

Cancer Risk-Reducing Opportunities in Gynecologic Surgery.
Carolyn Piszczek, Jun Ma, Claire H Gould, Paul Tseng. J Minim Invasive Gynecol 2018
2

Estimating the number of potential family members eligible for BRCA1 and BRCA2 mutation testing in a "Traceback" approach.
Haley A Moss, Goli Samimi, Laura J Havrilesky, Mark E Sherman, Evan R Myers. Genet Epidemiol 2018
1

Bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: A pilot study in women with BRCA1/2 mutations.
Denise R Nebgen, Jean Hurteau, Laura L Holman, Andrea Bradford, Mark F Munsell, Beth R Soletsky, Charlotte C Sun, Gary B Chisholm, Karen H Lu. Gynecol Oncol 2018
29



Surgical prevention strategies in ovarian cancer.
Adrianne Mallen, T Rinda Soong, Mary K Townsend, Robert M Wenham, Christopher P Crum, Shelley S Tworoger. Gynecol Oncol 2018
17

Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.
George U Eleje, Ahizechukwu C Eke, Ifeanyichukwu U Ezebialu, Joseph I Ikechebelu, Emmanuel O Ugwu, Onyinye O Okonkwo. Cochrane Database Syst Rev 2018
30

Cell Origins of High-Grade Serous Ovarian Cancer.
Jaeyeon Kim, Eun Young Park, Olga Kim, Jeanne M Schilder, Donna M Coffey, Chi-Heum Cho, Robert C Bast. Cancers (Basel) 2018
72

No. 366-Gynaecologic Management of Hereditary Breast and Ovarian Cancer.
Michelle Jacobson, Marcus Bernardini, Mara L Sobel, Raymond H Kim, Jeanna McCuaig, Lisa Allen. J Obstet Gynaecol Can 2018
3

No 366 - Prise en charge gynécologique du cancer du sein et de l'ovaire héréditaire.
Michelle Jacobson, Marcus Bernardini, Mara L Sobel, Raymond H Kim, Jeanna McCuaig, Lisa Allen. J Obstet Gynaecol Can 2018
0


Risk-reducing salpingectomy: Let us be opportunistic.
Kara C Long Roche, Nadeem R Abu-Rustum, Mlica Nourmoussavi, Oliver Zivanovic. Cancer 2017
18